title: Treatment options for pityriasis rubra pilaris including biologic agents: a retrospective analysis from an academic medical center.
authors.affiliation: Harvard Combined Dermatology Residency Program, Boston, Massachusetts.
authors.forename: A Brooke
authors.initials: AB
authors.lastname: Eastham
authors.affiliation: Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
authors.forename: Alisa N
authors.initials: AN
authors.lastname: Femia
authors.affiliation: Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts3Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
authors.forename: Abrar
authors.initials: A
authors.lastname: Qureshi
authors.affiliation: Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
authors.forename: Ruth Ann
authors.initials: RA
authors.lastname: Vleugels
mesh_terms: D000046:Academic Medical Centers; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016208:Databases, Factual; D003879:Dermatologic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007223:Infant; D008297:Male; D008875:Middle Aged; D010916:Pityriasis Rubra Pilaris / Q000473:pathology / Q000628:therapy*; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D003879:Dermatologic Agents; D007155:Immunologic Factors